Decitabine-cedazuridine as first line in acute myeloid leukaemia ineligible for conventional induction chemotherapy

被引：0
|
作者：
Tauveron-Jalenques, Urbain [1 ]
Lambert, Juliette [2 ]
机构：
[1] CHU Clermont Ferrand, Serv Therapie Cellulaire & Dhematol Clin Adulte, F-63100 Clermont Ferrand, France
[2] Ctr hospitalier Versailles, Serv Dhematol, F-78150 Le Chesna Rocquencourt, France
来源：
BULLETIN DU CANCER | 2024年 / 111卷 / 05期
关键词：
Acute myeloid leukaemia; AML; Decitabine; Cedazuridine; Hypomethylating agent; Unfit;
D O I：
10.1016/j.bulcan.2024.01.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：435 / 436
页数：2
相关论文
共 50 条
  • [1] Oral decitabine-cedazuridine in acute myeloid leukaemia
    Bouligny, Ian M.
    Dinardo, Courtney D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1674 - 1676
  • [2] Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
    Geissler, Klaus
    Koristek, Zdenek
    del Castillo, Teresa Bernal
    Novak, Jan
    Rodriguez-Macias, Gabriela
    Metzelder, Stephan K.
    Illes, Arpad
    Mayer, Jiri
    Arnan, Montserrat
    Keating, Mary-Margaret
    Krauter, Juergen
    Lunghi, Monia
    Fracchiolla, Nicola Stefano
    Platzbecker, Uwe
    Santini, Valeria
    Sano, Yuri
    Oganesian, Aram
    Keer, Harold
    Luebbert, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1734 - 1745
  • [3] Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy
    Bocchia, Monica
    Candoni, Anna
    Borlenghi, Erika
    Defina, Marzia
    Fili, Carla
    Cattaneo, Chiara
    Sammartano, Vincenzo
    Fanin, Renato
    Sciume, Margherita
    Sicuranza, Anna
    Imbergamo, Silvia
    Riva, Marta
    Fracchiolla, Nicola
    Latagliata, Roberto
    Caizzi, Emanuela
    Mazziotta, Francesco
    Alunni, Giulia
    Di Bona, Eros
    Crugnola, Monica
    Rossi, Marianna
    Consoli, Ugo
    Fontanelli, Giulia
    Greco, Giuseppina
    Nadali, Gianpaolo
    Rotondo, Francesco
    Todisco, Elisabetta
    Bigazzi, Catia
    Capochiani, Enrico
    Molteni, Alfredo
    Bernardi, Massimo
    Fumagalli, Monica
    Rondoni, Michela
    Scappini, Barbara
    Ermacora, Anna
    Simonetti, Federico
    Gottardi, Michele
    Deliliers, Daniela Lambertenghi
    Michieli, Mariagrazia
    Basilico, Claudia
    Galeone, Carlotta
    Pelucchi, Claudio
    Rossi, Giuseppe
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 447 - 455
  • [4] The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia
    Briski, Robert
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    Ravandi, Farhad
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [5] Induction chemotherapy in acute myeloid leukaemia: origins and emerging directions
    Upadhyay, Vivek A.
    Fathi, Amir T.
    CURRENT OPINION IN HEMATOLOGY, 2018, 25 (02) : 67 - 74
  • [6] A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
    Luebbert, Michael
    Rueter, Bjoern H.
    Claus, Rainer
    Schmoor, Claudia
    Schmid, Mathias
    Germing, Ulrich
    Kuendgen, Andrea
    Rethwisch, Volker
    Ganser, Arnold
    Platzbecker, Uwe
    Galm, Oliver
    Brugger, Wolfram
    Heil, Gerhard
    Hackanson, Bjoern
    Deschler, Barbara
    Doehner, Konstanze
    Hagemeijer, Anne
    Wijermans, Pierre W.
    Doehner, Hartmut
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03): : 393 - 401
  • [7] Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
    Ferrara, Felicetto
    HEMATOLOGICAL ONCOLOGY, 2014, 32 (01) : 1 - 9
  • [8] Decitabine: A Review of its Use in Older Patients with Acute Myeloid Leukaemia
    Monique P. Curran
    Drugs & Aging, 2013, 30 : 447 - 458
  • [9] Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapy
    Yamauchi, Takahiro
    Yoshida, Chikashi
    Usuki, Kensuke
    Takada, Satoru
    Matsumura, Itaru
    Dobashi, Nobuaki
    Miyazaki, Yasushi
    Miyamoto, Toshihiro
    Iida, Hiroatsu
    Asou, Norio
    Kuroda, Junya
    Ichikawa, Satoshi
    Komatsu, Norio
    Mendes, Wellington
    Honda, Hideyuki
    Okubo, Sumiko
    Kurokawa, Misaki
    Jiang, Qi
    Wei, Andrew
    Ishizawa, Kenichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (09) : 1372 - 1382
  • [10] Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia
    Matthews, JP
    Bishop, JF
    Young, GAR
    Juneja, SK
    Lowenthal, RM
    Garson, OM
    Cobcroft, RG
    Dodds, AJ
    Enno, A
    Gillett, EA
    Hermann, RP
    Joshua, DE
    Ma, DD
    Szer, J
    Taylor, KM
    Wolf, M
    Bradstock, KF
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (03) : 727 - 736
12345